JavaScript is disabled for your browser. Some features of this site may not work without it.
Get the latest COVID-19 technical guidance, scientific and policy briefs here.✕
    • العربية
    • 中文
    • English
    • français
    • русский
    • español
    • Deutsch
    • português
English
  • العربية
  • 中文
  • English
  • français
  • русский
  • español
  • Deutsch
  • português
  • Home
  • Contact
  • Help

Browse

All of IRISCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

Statistics

Most PopularBy Country

Related Links

PAHO IRIS

Growth advantage of CD34+ cells in trisomy 8 high-risk myelodysplastic syndrome despite enhanced apoptotic signals

Thumbnail
View/Open
2012_18_10_1065_1071.pdf (‎481.0Kb)‎
View Statistics
Show Statistical Information
Altmetrics
Share
  • CSV
  • Excel
  • BibTeX
  • RIS
Abstract
This study examined haematopoietic stem cells of 19 high-risk cases of myelodysplastic syndrome [‎MDS]‎ for apoptotic and anti-apoptotic signals and cellular proliferation and correlated these with clinical and cytogenetic subtypes, particularly trisomy 8. The aim was to identify cellular and cytogenetic markers of prognostic relevance to survival of high-risk MDS cases. High-risk MDS cases had a significantly higher percentage of apoptotic CD34+ cells and anti-apoptotic survivin+ cells than controls, particularly for trisomy 8 cases. Trisomy 8+ cells showed a significant positive correlation with apoptotic CD34+ cells and capacity for colony formation. The latter was significantly lower in trisomy-8-negative cases than normal controls, while that of trisomy 8 cases was comparable to controls. Our results suggest that although trisomy 8 cells are in a pro-apoptotic state, they are checked by the enhanced expression of anti-apoptotic signals which provide them with their proliferative advantage
Citation
Youssef, S.R., Ismail, M.M., Abd Al Wahed, E. & Al Dessoky, H. (‎2012)‎. Growth advantage of CD34+ cells in trisomy 8 high-risk myelodysplastic syndrome despite enhanced apoptotic signals. EMHJ - Eastern Mediterranean Health Journal, 18 (‎10)‎, 1065-1071, 2012 https://apps.who.int/iris/handle/10665/118509
Journal
EMHJ - Eastern Mediterranean Health Journal, 18 (‎10)‎, 1065-1071, 2012
Description
1065-1071
ISSN
1020-3397
Other Identifiers
http://applications.emro.who.int/emhj/v18/10/2012_18_10_1065_1071.pdf
Language
English
Collections
  • EMRO Journal Articles (‎EMHJ)‎
Metadata
Show full item record

Show Statistical Information

View Item 
  • IRIS Home
  • 4. Regional Office for the Eastern Mediterranean
  • EMRO Journal Articles (‎EMHJ)‎
  • View Item
  • IRIS Home
  • 4. Regional Office for the Eastern Mediterranean
  • EMRO Journal Articles (‎EMHJ)‎
  • View Item

© 2021 WHO